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a b s t r a c t
Ash from dome-forming volcanoes poses a unique hazard to millions of people worldwide due to an
abundance of respirable cristobalite, a crystalline silica polymorph. Crystalline silica is an established
respiratory hazard in other mixed dusts, but its toxicity strongly depends on sample provenance. Pre-
vious studies suggest that cristobalite-bearing volcanic ash is not as bio-reactive as may be expected for a
dust containing crystalline silica. We systematically address the hazard posed by volcanic cristobalite by
analysing a range of dome-related ash samples, and interpret the crystalline silica hazard according to
the mineralogical nature of volcanic cristobalite. Samples are sourced from ﬁve well-characterized dome-
forming volcanoes that span a range of magmatic compositions, speciﬁcally selecting samples rich in
cristobalite (up to 16 wt%). Isolated respirable fractions are used to investigate the in vitro response of
THP-1 macrophages and A549 type II epithelial cells in cytotoxicity, cellular stress, and pro-inﬂammatory
assays associated with crystalline silica toxicity. Dome-related ash is minimally reactive in vitro for a
range of source compositions and cristobalite contents. Cristobalite-based toxicity is not evident in the
assays employed, supporting the notion that crystalline silica provenance inﬂuences reactivity. Macro-
phages experienced minimal ash-induced cytotoxicity and intracellular reduction of glutathione; how-
ever, production of IL-1β, IL-6 and IL-8 were sample-dependent. Lung epithelial cells experienced
moderate apoptosis, sample-dependent reduction of glutathione, and minimal cytokine production. We
suggest that protracted interaction between particles and epithelial cells may never arise due to effective
clearance by macrophages. However, volcanic ash has the propensity to incite a low, but signiﬁcant, and
sample-dependent response; the effect of this response in vivo is unknown and prolonged exposure may
yet pose a hazard.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Given the established hazard posed by respirable crystalline
silica (CS) in occupational settings, the presence of cristobalite, a
CS polymorph, in ash emerged as a primary health concern during
the 1980 eruption of Mount St. Helens, USA (Green et al., 1981),
and again during the 1995-present eruption of Soufrière Hills
volcano, Montserrat (Baxter et al., 1999; Wakeﬁeld, 2000), gaining
the attention of governments and international public health and
toxicology experts (Baxter et al., 2014). As a result, detection of CS
in volcanic ash has been undertaken in response to many
eruptions worldwide, and is central to rapid hazard assessments
carried out by the International Volcanic Health Hazard Network
(e.g., Damby et al., 2013; Horwell et al., 2013a). However, the
consequence of regular exposure to volcanic cristobalite is still
unknown, even in areas with prolonged exposure; for example,
the densely populated regions surrounding Mt. Sakurajima, where
persistent small eruptions frequently expose the population to ash
containing up to 5 wt% cristobalite (reviewed by Hillman et al.
(2012)).
Comprehensive risk assessments to determine the long-term
risk of silicosis arising from chronic exposure to cristobalite-
bearing ash have been conducted only for the eruptions of Mount
St. Helens and Soufrière Hills (Horwell and Baxter, 2006). As a
non-occupational risk of silicosis had never been recognized prior
to the Mount St. Helens eruption, these assessments relied on
occupational approaches, for which determination of exposure to
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crystalline silica is central; however, the toxicity of volcanic cris-
tobalite had not yet been established (Baxter et al., 2014). Despite
substantial variability in discrete in vitro and in vivo toxicology
results for volcanic ash to date (see Baxter et al. (2014) and Hor-
well and Baxter (2006) for a full review), there is a tacit assump-
tion in the literature that observed toxicity may result from the
presence of CS (e.g., Sanders et al., 1983; Wehner et al., 1986).
However, no notable intra-study differences in reactivity among
samples with variable cristobalite contents have been observed
(e.g., Housley et al., 2002; Vallyathan et al., 1983; Wilson et al.,
2000).
The respiratory hazard posed by CS in other mixed dusts is
dependent on the provenance of the sample, leading CS reactivity
to be deemed a ‘variable entity’ (Donaldson and Borm, 1998).
Volcanic cristobalite is particularly abundant in ash from dome-
forming volcanoes (Damby, 2012), where mounds of viscous lava
pile up over the vent. The active dome environment facilitates the
in situ crystallization of cristobalite in these lavas through vapour-
phase deposition in cracks and pore space and through devi-
triﬁcation of volcanic glass (Baxter et al., 1999; Horwell et al.,
2013b). The presence of cristobalite in ash, therefore, requires in-
corporation of existing lavas during an eruption, and can comprise
upwards of 25 wt% of the ash (Damby, 2012; Horwell et al., 2014).
Its abundance depends on dome residence time and lava extrusion
rate as well as the eruptive style by which the ash is generated
(Horwell et al., 2014). For example, ash from the initial 2008
eruption of Chaitén volcano contained 2 wt% cristobalite,
whereas subsequent eruptions after dome growth began con-
tained 13–19 wt% (Horwell et al., 2010).
The inﬂuence of source environment and mineralogy on toxi-
city has recently been considered for volcanic cristobalite,
whereby natural substitutions of aluminium for silicon are shown
to affect the chemistry and structure of volcanic cristobalite re-
lative to pure-phase samples (Damby et al., 2014; Horwell et al.,
2012). Horwell et al. (2012) suggest that these substitutions could
potentially reduce the toxicity of volcanic cristobalite, as alumi-
nium has been shown experimentally to quell CS toxicity (Dufﬁn
et al., 2001). Further, Horwell et al. (2012) show that discrete ash
grains from Soufrière Hills volcano are mineralogically hetero-
geneous, effectively reducing the surface area of cristobalite at the
particle surface.
Despite the present geological understanding, interpreting and
contextualizing the hazard posed by different and/or new volcanic
eruptions has been difﬁcult. Direct inter-study comparisons are
problematic as variably sourced ash comprises different miner-
alogical constituents and eruptive histories, and because previous
toxicological assessments typically focus on single locations. Only
two studies have considered multiple source volcanoes: the ﬁrst,
by Vallyathan et al. (1984), considered three volcanoes (Mount St.
Helens, El Chichón, and Galunggung); however, their respirable
samples only contained 1.5 to 2.0% CS; the second, by Horwell
et al. (2013a), benchmarks cristobalite-free ash from the 2010 and
2011 eruptions of Eyjafjallajökull and Grímsvötn, Iceland against a
cristobalite-rich sample from Soufrière Hills volcano. Inter-study
comparisons are further hindered by differences in experimental
design. For example, haemolysis assays on Soufrière Hills ash by
Cullen et al. (2002) and Wilson et al. (2000) both use sheep ery-
throcytes and a top particle dose of 20–30 mg ml1 whereas
Horwell et al. (2013a) use fresh human erythrocytes and a top dose
of 1 mg ml1. Consequently, Soufrière Hills ash has ranged from
0 to 45% haemolysis in studies that cannot be directly compared.
Within these studies, samples from the same volcano, and even
same eruptive phase, have elicited different responses (e.g., Hor-
well et al. (2013a) and Wilson et al. (2000)).
Here, we systematically evaluate the in vitro response elicited
by respirable cristobalite-bearing volcanic ash from ﬁve dome-
forming volcanoes, speciﬁcally selecting samples rich in CS, to
understand the toxicity of volcanic cristobalite. This is ﬁrst study
to speciﬁcally investigate the reactivity of volcanic cristobalite as
well as the ﬁrst to consider the toxicity of ash derived from an
exceptional range of magmatic compositions. We assess the ash-
induced decrease in viability and pro-inﬂammatory activation of
macrophages and alveolar type II epithelial cells. Macrophages are
classically considered a crucial cell type in the initiation and pro-
gression of pulmonary inﬂammation due to their wide spectrum
of pro-inﬂammatory cytokine production and direct role in parti-
cle clearance, and type II epithelial cells are thought to play a key
role in pulmonary inﬂammation and ﬁbrogenesis, including in
response to CS exposure (Driscoll et al., 1993). Ash samples from
Mount St. Helens and Soufrière Hills volcano (discussed above)
contextualize the present study due to the wealth of previous
health-focused studies (see Horwell and Baxter (2006) for a re-
view). Further cristobalite-bearing samples are analysed from Mt.
Unzen (Japan), Volcán de Colima (Mexico) and Mt. Merapi (In-
donesia) due to their location in densely populated areas and
history of violent eruptions, factors which led to their designation
as Decade Volcanoes by the United Nations as part of a disaster-
reduction effort; thus, understanding the respiratory hazard posed
by these volcanoes is crucial.
2. Methods
2.1. Samples of volcanic ash
Volcanic ash samples were sourced from 5 dome-forming
volcanoes, ranging from basaltic-andesite to dacite in composition
(Table 1). Samples were selected from a larger sample suite to
maximize the CS contents of the samples analysed (see Damby
(2012)). Mineralogically, these samples primarily comprise volca-
nic glass, feldspars, pyroxenes, amphiboles, Fe–Ti oxides, and
crystalline silica polymorphs (see Supplementary material). All
samples were generated from eruptions involving dome material
but were derived from a range of eruptive styles due to the dif-
ferent eruptive natures of the volcanoes studied. Two samples
were selected from Merapi to consider the effect of different
Table 1
Sample information for the respirable ash panel. All ash samples were generated in the presence of a volcanic dome. Cristobalite abundance was determined by the IAS
method of Le Blond et al. (2009) and has a73 wt% error.
Sample Source Ash type Eruption date Collection date Distance to source (km) Cristobalite (wt%)
COL Colima, Mexico Vulcanian explosion unknown 21/03/2010 o0.2 5.7
MER Merapi, Indonesia Dome collapse 11–19/07/1998 09/08/1998 0.2 2.7
MER.PDC Merapi, Indonesia Pyroclastic density current 05/11/2010 30/11/2010 17.0 6.2
MSH Mount St. Helens, USA Vent explosion 08/03/2005 10/03/2005 6.5 15.3
SHVa Soufrière Hills, Montserrat Dome collapse 05/06/1999 05/06/1999 4.0 15.7
UNZ Unzen, Japan Dome collapse 03/04/1993 03/04/1993 5.0 7.3
a SHV is the same as sample MRA5/6/99 in Horwell et al. (2003).
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fragmentation mechanisms on the particle hazard and are dis-
tinguished by the designation ‘PDC’, which denotes the sample
derived from a pyroclastic density current (PDC) deposit rather
than ashfall. Further information on each volcano can be found in
the Supplementary material.
Respirable fractions were isolated at SAFENANO, Institute of
Occupational Medicine, Edinburgh. Approximately 5 g of bulk
volcanic ash was aerosolised with HEPA-ﬁltered compressed air
using an AERO PA100 particle aerosoliser. The aerosol was passed
through a gravitational separator where large particles and ag-
glomerates sedimented from the aerosol in accordance with Sto-
ke's Law. Particles below a maximum theoretical aerodynamic
diameter of 6 mm (i.e., within the respirable range; Brown et al.,
2013), calculated for a speciﬁc airﬂow and particle density in the
system, then entered a sampling chamber for collection.
2.2. Particle size distribution and morphologies
The particle size distribution of the respirable particulate
aerosols was analysed concurrent with separation by two real-
time instruments: a Fast Mobility Particle Sizer (FMPS; model
3091, TSI Inc.) and an Aerodynamic Particle Sizer (APS; model
3320, TSI Inc.). The FMPS measures particles from 5.6 to 560 nm
based on electrical mobility and the APS measures particles from
500 to 20,000 nm by light scattering. By overlapping the two in-
strument readings at their detection boundaries, a total range of
5.6 nm to 20 mm was analysed. Data were recorded over a 15–
30 min period.
Size-classiﬁed respirable ash was imaged by scanning electron
microscopy (SEM) to conﬁrm the upper particle size cut-off and to
consider particle morphology and cristobalite habit. Cristobalite
was conﬁrmed by energy dispersive X-ray spectroscopy (EDS).
Imaging and chemical analysis was carried out on a Hitachi SU-70
FEG SEM equipped with an Oxford Instruments EDS system (IN-
CAx-act LN2-free analytical Silicon Drift Detector) in the GJ Russell
Microscopy Facility, Department of Physics, Durham University.
2.3. Quantiﬁcation of crystalline silica phases
The abundance of CS as cristobalite, quartz and tridymite was
quantiﬁed by X-ray diffraction (XRD) using the IAS method of Le
Blond et al. (2009). This method allows for quantiﬁcation of single
phases without prior determination of a sample's bulk mineralogy.
Experiments were performed on an Enraf-Nonius X-ray dif-
fractometer with an INEL curved position sensitive detector at the
Natural History Museum, London, UK. Single phases were quan-
tiﬁed as outlined in Le Blond et al. (2009) using Nonius GUFI
software. Phase quantiﬁcations are an average of 2 experiments
and have73 wt% error.
2.4. Treatment of cell cultures with respirable ash
The human leukaemic monocytic THP-1 cell line was main-
tained in continuous suspension using RPMI 1640 medium con-
taining 10% heat-inactivated FBS (PAA Laboratories, Ltd., UK)
supplemented with 2 mM L-Glutamine, penicillin (100 units ml1)
and streptomycin (100 mg ml1). Cells were seeded at a density of
5105 cells ml1 in 12-well plates and differentiated to express a
macrophage phenotype with 10 ng ml1 PMA (Sigma-Aldrich, UK)
for 48 h. Prior to particle treatment, the media was replaced with
serum-free RPMI media (supplemented as above) for 24 h.
A549, a human adenocarcinoma-derived type II alveolar epi-
thelial cell line, was maintained in continuous culture in DMEM
growth media with 10% FBS and supplemented with L-Glutamine,
penicillin and streptomycin as per the THP-1 cell media. To pre-
pare cells for particle treatment, cells were trypsinized using a
0.25% solution and allowed to re-adhere overnight. Treatment was
performed on 1 ml of cells at a density of 5105 cells ml1 in each
well of a 12-well plate. Both cell lines were maintained at 37 °C in
a 5% CO2 environment.
Cells were treated for 24 h with four concentrations of volcanic
ash and control particles: 5, 10, 25 and 50 mg cm2. DQ12 quartz
was used as a positive control, as CS is of primary concern and
DQ12 toxicity is well established in the assays employed and is
utilised extensively in previous ash toxicity studies (see Horwell
and Baxter (2006)). TiO2 (rutile) was used as a negative control.
Volcanic ash was suspended in the appropriate cell-line media
without FBS and sonicated for 10 min to disaggregate the particles.
Mass was used as the metric since mass is the current metric for
CS and nuisance dusts in the workplace globally.
2.5. Assessment of cytotoxicity
The extent of cytolysis was determined by lactate dehy-
drogenase (LDH) release. Culture medium was transferred to
1.5 ml microcentrifuge tubes and spun at 12,000g for 10 min to
remove any cell debris and remaining particulate. 35 ml of cell-free
culture supernatant was transferred in triplicate to a 96 well plate
and each well diluted with 70 ml of phosphate buffered solution
(PBS). 100 ml of LDH test reagent (Roche Diagnostics, Mannheim,
Germany) was added to each well. The absorbance was de-
termined at 490 nm after 30 min using a Synergy HT microplate
reader (BioTek Instruments, Inc., VT, USA). The level of LDH release
is expressed as a percentage of total LDH release from complete
cell lysis by Triton X-100. Data are expressed as the average of
3 experiments.
Cell viability was determined using the alamarBlues cell pro-
liferation assay. Following particle treatment, the supernatant was
removed and the cells washed with PBS. 300 ml of PBS and 30 ml of
alamarBlues (Invitrogen, Life Technologies, CA, USA) was added to
each well. THP-1 cultures were incubated for 1 h and A549 cul-
tures for 30 min at 37 °C in 5% CO2. The solution was spun at
12,000g for 5 min, as the particles interfered with the readings,
and transferred to a 96 well plate to be read spectro-
photometrically at 570 nm. Cell viability is expressed as a per-
centage of base line viability (no particle treatment) using Triton
X-100 as complete cell death. Data are expressed as the average of
3 experiments.
2.6. Determination of apoptosis, necrosis, and cellular stress
The extent of apoptosis, necrosis and endogenous antioxidant
production was determined by ﬂuorescence-activated cell sorting
(FACS). FITC-conjugated Annexin V staining was used to determine
the percentage of cells actively undergoing apoptosis. Propidium
iodide (PI) was used to distinguish viable from non-viable (ne-
crotic) cells. Monochlorobimane (MCB) was used to measure in-
tracellular concentrations of glutathione (GSH), the principal in-
tracellular low-molecular-weight thiol.
Supernatants from post-exposure THP-1 and A549 cell cultures
were collected and spun at 1500 RPM for 3 min to recover non-
adherent cells. Adhered cell monolayers were washed with PBS
(without Ca and Mg) 2 and trypsinized (5 min, 37 °C, 5% CO2),
the trypsin neutralised with culture media, and recovered cells
were added to previously collected cells. Collected cells were
washed 3 at 1500 RPM for 3 min and re-suspended in Annexin
buffer (Hank’s Balanced Salt Solution with 2.5 mM CaCl2, ﬁlter
sterilised). Cells were stained with 5 ml FITC-Annexin V and 1 ml
MCB per 195 ml cell suspension and incubated for 10 min. Cells
were spun at 1500 RPM for 3 min and re-suspended in 200 ml
Annexin buffer. PI (1 ml) was added immediately prior to ﬂow cy-
tometry. Unstained cells and unstained particle-treated cells were
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analysed to control for differences in size and granularity resulting
from phagocytosis of ash. Untreated stained cells (negative vehicle
controls) were analysed, as were a necrotic control (10 mM H2O2),
an apoptotic control (amine beads at 50 mg ml1), and a GSH
control (N-ethylmaleimide; NEM).
2.7. Assessment of the pro-inﬂammatory response
Enzyme-linked immunosorbent assays (ELISA) were used for
the quantiﬁcation of acute-phase cytokines IL-1β, IL-6 and che-
mokine IL-8 produced following particle treatment using cyto-
kine-speciﬁc ELISA DuoSet kits (R&D Systems, Abingdon, UK) ac-
cording to the manufacturer's protocol. Cytokine concentrations
were determined spectrophotometrically at 450 nm via extra-
polation of a recombinant cytokine protein standard curve.
2.8. Imaging of cell-particle interaction
Differentiated THP-1 cells were imaged by light microscopy
following ash treatment to determine whether particles were
being internalised. Only THP-1 cells were imaged as A549 ag-
gregated during preparation. Cytospin preparations were made by
centrifuging 40 to 60,000 cells in 300 ml of 0.1% BSA/sterile sal-
ine solution at 300 RPM for 3 min at room temperature using a
Cytospin 4 centrifuge (Thermo Scientiﬁc, UK). Air-dried slides
were ﬁxed in 100% methanol and stained with eosin (Quick-Diff,
Dade Behring, Inc.) and haematoxylin (REASTAIN Quick-Diff Blue),
and then submerged in xylene for 30 s. DPX mounting media
(Sigma-Aldrich, Poole, UK) was added directly to the cell popula-
tion and slides were covered with a glass cover slip. Images were
captured at 100 magniﬁcation using QCapture Pro software
(Media Cybernetics, Inc., Bethesda, MD).
2.9. Statistical analysis
Statistical analysis was performed using GraphPad PRISM
software (San Diego, CA). Multiple comparisons were conducted
using two-way analysis of variance (ANOVA) with Tukey's post-
test where appropriate. In all cases, tests were considered sig-
niﬁcant when pr0.05.
3. Results
3.1. Particle characterisation
Sizing of the size-separated samples yielded distributions ran-
ging from 0.08 mm to 7.0 mm (Fig. 1); the distribution was similar
for all samples. A bi-modal distribution arises from combining
results from FMPS and APS (Fig. 1); however, this is likely due to
instrumentation and is not considered further. The gradual slope
towards the upper size cut-off (7.0 mm) is likely a physical ar-
tefact as the probability of re-suspension decreases towards the
deﬁned particle cut-off (6 mm). The lower cut-off (0.08 mm) is
not likely representative of a true minimum particle size as par-
ticles are subject to aggregation.
SEM imaging of the isolated ash substantiates the particle size
data, and reveals little difference in general morphology among
samples (Fig. 2a and b). Particles are poorly vesiculated, sub-an-
gular and blocky with varying amounts of nano-scale particles
adhering to the surfaces of larger particles. Only scarce mineral
ﬁbres were observed in any of the samples. Cristobalite was pre-
sent in all respirable samples, ranging from 3 to 16 wt% (Table 1).
Minor quartz was detected in samples SHV, MSH and UNZ. No
tridymite was observed in any sample. SEM backscattered imaging
of ash in cross section conﬁrms that discrete ash grains can
contain cristobalite intimately associated with other mineral
phases and glass (Fig. 2c) whereas others solely comprise cristo-
balite (Fig. 2d). Further, all cristobalite contains aluminium
(Fig. 2d), extending the observations of Horwell et al. (2012) to the
respirable fraction.
3.2. Cytotoxicity of differentiated THP-1 and A549 cells
All samples induced some degree of decreased viability in THP-
1 macrophages at 24 hours as measured by metabolism of the
alamarBlues reagent (Fig. 3a). However, the response to ash did
not follow a typical dose-dependent decrease as exempliﬁed by
DQ12 quartz. The decrease in viability is similar to that elicited by
TiO2 (consistent 85% viability over the same dose range). A similar
response was seen for LDH release (Fig. 3b), where treatment re-
sulted in substantially lower release than DQ12 and marginally
lower release than TiO2.
A549 cell viability determined by the alamarBlues assay
showed little effect of particle treatment compared to DQ12 and
TiO2 (Fig. 3c). Ash samples MER, COL, UNZ elicited more LDH re-
lease than TiO2 but less than DQ12 (Fig. 3d).
3.3. Assessment of apoptosis and necrosis
Differentiated THP-1 cells experienced limited reduction in
viability following particle treatment as determined by FACS
analysis (Fig. 4); THP-1 cell necrosis and apoptosis were roughly
equivalent and negligible. A549 cells experienced a 20% reduc-
tion in viability, which was largely attributed to apoptosis (Fig. 4);
all samples resulted in a signiﬁcant level of apoptosis over un-
treated control.
3.4. Intracellular oxidative stress
No reduction in GSH abundance was observed with ash treat-
ment in THP-1 cells compared to untreated cells (Fig. 4). However,
an ash-induced reduction was observed for A549 cells (Fig. 4),
with UNZ and COL causing the most pronounced depletion relative
to controls. The extent of the decrease was more pronounced for
higher doses; in general, the effect was more prominent that that
caused by DQ12 quartz but substantially less than that produced
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by NEM, an effective oxidiser of GSH which rapidly depletes it
from the cell cytosol.
3.5. Pro-inﬂammatory response
The pro-inﬂammatory response of differentiated THP-1 cells
was sample and cytokine dependent. The top two doses (25 and
50 mg cm2) of SHV, MER and MER.PDC resulted in the production
of IL-1β above the untreated control and were equivalent to the
lowest dose (5 mg cm2) of DQ12 (Fig. 5a). Treatment by all sam-
ples except for MER resulted in IL-6 production comparable to the
untreated control (Fig. 5b). One repeat experiment (of n¼3) for
MER resulted in similar levels to all other samples, resulting in
large error bars and perhaps emphasizing the heterogeneous mi-
neralogy of the ash samples. Cells treated with both UNZ and MER
produced signiﬁcantly more IL-8 than untreated cells in a dose-
dependent response (Fig. 5c). Levels for the top dose (50 mg cm2)
of these samples were also greater than that induced by equivalent
concentrations of DQ12. Although MER induced signiﬁcant IL-8
production, results for MER.PDC were largely negative.
The response of A549 epithelial cells to insult was largely ne-
gative (Fig. 5d–f). Little to no release of IL-1β or IL-6 occurred,
especially compared to that induced by DQ12. Production of IL-8
for all particle treatments (ash and DQ12) did not differ sig-
niﬁcantly from an untreated control (p40.05), suggesting mini-
mal treatment-dependent production of IL-8 over a basal level.
3.6. Particle-Cell imaging
Light microscope imaging of untreated and ash-treated differ-
entiated THP-1 cells in cytospin preparations shows that particles
were internalised by cells (Fig. 6). Using the techniques here, it was
not possible to determine if there was a preferential uptake or
retention of certain mineral phases relative to others.
4. Discussion
4.1. Differentiated THP-1 cell response
Phagocytosis of particles by THP-1 macrophages resulted in
minimal cytotoxicity, as evidenced by low levels of LDH release,
minimal suppression of cellular metabolism, and negligible
apoptosis and necrosis. These results agree with previous studies
on alveolar macrophages, which generally show no ash-dependent
changes in viability (e.g., Fruchter et al., 1980; Green et al., 1982;
Huang et al., 2004; Martin et al., 1984); however, one study has
shown moderate cytotoxicity to macrophages exposed to Mount
St. Helens ash (McLemore et al., 1984). THP-1 cells also appear to
have increased intracellular GSH levels following ash exposure.
Macrophages are known to have lower levels of intracellular GSH
than other cell types (e.g., 10 nmol mg1 protein compared to
150 nmol mg1 protein in A549 cells) (Biswas and Rahman, 2009),
and perhaps increase production to cope with insult. This would
have the effect of increasing antioxidant defence in response to
exposure. Collectively, these cytotoxicity and cellular stress data
suggest that clearance by macrophages should be effective with
little impairment to the cell at plausible exposures.
It is not possible to assign the pro-inﬂammatory response of
THP-1 macrophages to CS abundance alone. Production of IL-1β,
which is important in the development of silica-related disease
(Mossman and Glenn, 2013), was negligible for MSH (as also
Fig. 2. Scanning electron micrographs of respirable volcanic ash. Selected SEM micrographs of respirable volcanic ash samples (a) UNZ and (b) SHV, which are representative
of all samples investigated. Backscattered SEM images of ash sample SHV in cross section showing (c) heterogeneous patches of cristobalite labelled ‘c’ (cristobalite crystal
boundaries are demarcated), and (d) a particle comprised entirely of cristobalite. Inset: EDS spot analysis of cristobalite showing the presence of aluminium and sodium. All
images were collected at 6.0 kV and 14 mm working distance.
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reported for Mount St. Helens ash by Bonner et al. (1998) and
Huang et al. (2004)), which contains the most CS (together with
SHV, within error), yet pronounced for MER, which contains the
least CS. These data support the adherence of volcanic cristobalite
to the ‘variable entity’ description of CS (Donaldson and Borm,
1998), as proposed by Horwell et al. (2012), whereby ‘inherent
characteristics and external factors' may affect the propensity of CS
to incite IL-1β production.
An increase in the production of IL-8, a potent chemoattractant
and activator of neutrophils, was only observed for low CS-content
samples UNZ and MER; a similar inability to stimulate neutrophil
chemotactic activity was previously observed for Mount St. Helens
ash (Martin et al., 1984). IL-8 transcription is under the control of
Nuclear Factor-κB (NF-κB), a transcriptional regulator protein
complex that becomes activated following CS exposure (Schins
and Donaldson, 2000); NF-κB has been shown to play a role in
discriminating between inﬂammogenic and non-inﬂammogenic
quartz varieties (Dufﬁn et al., 2001). However, like IL-1β produc-
tion, IL-8 production does not correlate with CS content. Since NF-
κB is an oxidative stress-responsive transcription factor involved
in the pro-inﬂammatory effects of many pathogenic particles
(Schins and Donaldson, 2000), again, CS cannot be independently
implicated.
4.2. A549 cell response
In general, A549 cells experienced a moderate reduction in cell
viability in response to ash treatment. These data agree with the
results of Wilson et al. (2000), where exposure of A549 cells to
three samples of respirable ash from Soufrière Hills resulted in a
similar decrease in viability to both DQ12 and TiO2, which were
not statistically different in their study. Results for individual ash
samples, however, did not always correspond among assays. For
example, COL was the most cytotoxic by LDH and alamarBlues
assays but induced the lowest amount of apoptosis and necrosis.
The propensity of all samples towards apoptosis rather than ne-
crosis aligns with previous work using Mount St. Helens ash on
lung epithelial cells (Agopyan et al., 2004), and may help explain
low haemolysis results for ash in previous studies (e.g., Damby
et al., 2013; Horwell et al., 2013a) as membranolysis would con-
stitute necrosis.
Despite the decrease in viability, no pro-inﬂammatory response
by A549 cells was observed above untreated control. Exposure of
A549 cells to pure-phase crystalline and amorphous silica is ex-
pected to result in the release of IL-8 and IL-6, with CS being the
most potent inducer of IL-8 and amorphous silica of IL-6 (Hetland
et al., 2001; Monteiller et al., 2007). Contrary to the above studies,
the amorphous component of volcanic ash failed to incite pro-
duction of IL-6, and the CS component of volcanic ash did not
result in the production of IL-8 above untreated control, especially
considering that both MSH and SHV comprised 15 wt% cristo-
balite. However, variability in the response of cultured cells to
exposure is well known, and the response can vary over time
(Poland et al., 2014).
Lung lining ﬂuid contains high concentrations of antioxidants
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Fig. 3. Cytotoxicity of ash samples towards differentiated THP-1 and A549 cells. Cytotoxicity of THP-1 cells following exposure to respirable ash and controls measured by
(a) metabolism of the alamarBlue reagent and (c) LDH release. Cytotoxicity of A549 cells measured by (b) metabolism of the alamarBlue reagent and (d) LDH release. Error
bars are the standard error of the mean. *pr0.05, **pr0.01.
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that form a protective barrier for the lung from oxidative and other
damage; depletion of this antioxidant defence can result in oxi-
dative stress to the underlying epithelial cells (Kelly et al., 1996).
Depletion of the high concentrations of GSH (a primary anti-
oxidant secreted by epithelial cells) in the lung lining ﬂuid has
been observed for various particles and ﬁbres (Brown et al., 2000);
however, studies on volcanic ash fromMerapi (Damby et al., 2013),
and Eyjafjallajökull and Grímsvötn, Iceland (Horwell et al., 2013a)
have shown no evidence of particle oxidative capacity in compo-
site respiratory tract lining ﬂuid (including GSH) or ascorbate de-
pletion assays, despite volcanic ash showing pronounced iron-
mediated free radical activity (Horwell et al., 2007). Therefore, the
extent of intracellular GSH reduction was unexpected. A549 cells
are known to have a higher level of GSH than primary epithelial
cells (150 nmol mg1 protein versus 60 nmol mg1 protein) (Bis-
was and Rahman, 2009); therefore, the ability of cells to buffer
these effects in vivo could be more pronounced.
4.3. Reactivity of volcanic cristobalite
The CS hazard was not evident in cytotoxicity assays nor in-
dicators typically associated with CS toxicity since samples MER
and SHV were marginally more reactive than the other samples for
all indicators of toxicity (except glutathione reduction in A549
cells) yet contained the least and most cristobalite of all samples
analysed (3 wt% versus 16 wt%, respectively). Further, no corre-
lation was seen between cristobalite abundance and the toxicity
responses evaluated when considering the samples collectively as
a continuum of cristobalite abundances (Table 2). These results
agree with the comparative study of respirable ash by Vallyathan
et al. (1984), where samples showed wide differences in haemo-
lysis and cytotoxicity despite all samples containingo2.0 wt% CS.
As such, much of the observed toxicity and surface reactivity of ash
(in this study and others) stems from factors that cannot be di-
rectly attributed to CS content.
These results also complement recent in vitro assessments of
chronic toxicity using type 1-like (TT1) lung epithelial cells. Ana-
lysis with samples from Merapi (Damby et al., 2013), Soufrière
Hills (Horwell et al., 2013a), and the Icelandic volcanoes Ey-
jafjallajökull and Grímsvötn (Horwell et al., 2013a) indicate pro-
longed production of IL-6, IL-8 and MCP-1; however, as in the
present study, the response is not mediated by CS, since the pro-
inﬂammatory response to samples from CS-bearing Merapi and
Soufrière Hills (including the bulk sample that corresponds to SHV
in the present study) resolved, whereas the response to the CS-free
Iceland samples persisted, and increased in some cases.
The limited apparent CS-based toxicity of cristobalite-bearing
ash could plausibly result from two possibilities. First, in ad-
herence to the variable-toxicity theory for CS, the limited re-
activity of volcanic cristobalite may reﬂect compositional or
structural modiﬁcation from pure SiO2 (due to the substitution of
Al), its presence in heterogeneous particles, and/or dissolution of
other minerals phases present in volcanic ash (Damby et al., 2014;
Horwell et al., 2012). The proportion and presence of other mineral
phases will differ due to differences in the source composition and
eruptive history of these samples, but the major constituents other
than CS were not characterised in detail as these phases have no
history of inducing inﬂammation (Bérubé et al., 2004; Housley
et al., 2002); however, they may modulate the response to volcanic
cristobalite.
The second possibility is simply that the CS burden per unit
dose is not sufﬁciently high to elicit a response. It is possible that a
toxicity threshold exists for the cristobalite content of ash, as ob-
served for CS in other mixed dusts (e.g., 10–15 wt% quartz in coal
dust; Le Bouffant et al., 1982), which may be substantiated here by
the equivalent production of IL-1β by THP-1 cells for the top dose
of some samples (MER, MER.PDC, and SHV) to the lowest dose of
DQ12 (Fig. 5a); however, the practical implications of a higher
threshold may be limited since a maximum of 23 wt% cristobalite
was observed in a study speciﬁcally tracking cristobalite abun-
dance in ash from Soufrière Hills (Horwell et al., 2014). Moreover,
as mentioned above, Horwell et al. (2012) show that ash surfaces
are heterogeneous (which is conﬁrmed in the present study for
respirable ash; Fig. 2c), reducing the available CS. However, this
restraint on surface CS alone may be insufﬁcient to account for the
limited response, since Jones and BéruBé (2011) implicate a bio-
available cristobalite fraction in ash.
4.4. Respiratory hazard of volcanic ash
Exposure to volcanic ash showed little cytotoxicity to macro-
phages by the assays employed here, limiting concern over the
consequences of persistent in vivo exposure due to concomitant
release of phagocytosed particles from cell death. Therefore, little
protracted interaction between the particles and epithelial cells is
expected. However, exogenous IL-1β has been shown to augment
alveolar epithelial cell survival by reducing apoptosis (Geiser et al.,
2000), and IL-1β can be provided (to some extent) by macro-
phages challenged with volcanic ash. In vivo, this may facilitate
epithelial survival during clearance of ash, but it may also allow
cells with DNA damage that should have undergone apoptosis to
persist and can be seen as a pre-carcinogenic effect. Indeed, such
effects must be considered alongside previously observed type II
pneumocyte hyperplasia (Akematsu et al., 1982). These
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expectations may extend to volcanic ash in general, as in vitro
exposure to cristobalite-free Eyjafjallajökull ash had minimal ef-
fect on innate immunity (Monick et al., 2013), comprising non-
statistical impairment of alveolar macrophage function and no
decrease in airway epithelial cell integrity.
Previous studies have shown that exposure to both CS and non-
CS bearing ash correlates with an increased risk of bacterial in-
fection (e.g., Castranova et al., 1982; Monick et al., 2013), which
may be augmented by acute inﬂammatory effects induced by
particle exposure (Sandberg et al., 2012). Opportunistic bacterial
infections, like tuberculosis, are widespread in many countries
with active volcanism, especially Indonesia, which ranks ﬁfth in
the world for pulmonary tuberculosis (World Health Organisation,
2011), and may be exacerbated by crystalline silica exposure
(Balmes, 1990). Evidence from the present study, and those dis-
cussed above, indicates a general potential for ash to induce (or
exacerbate) inﬂammatory disorders, irrespective of CS content; as
such, we suggest further consideration of complications resulting
from ash exposure.
5. Conclusion
The overall effects of a range of cristobalite-bearing ash were
low and did not correlate to cristobalite abundance. It is likely a
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combination of both ‘intrinsic and external factors' and dosimetry
that accounts for the suppressed reactivity of volcanic cristobalite.
However, these data, in conjunction with other studies, indicate
the potential for volcanic ash to initiate an inﬂammatory response
without seriously compromising lung cell function or integrity.
Consequently, prolonged exposure may yet pose a hazard, and the
general potential of ash to incite a response should be considered
in risk assessments of long-term complications arising from
chronic exposure.
Critically, the results of the present study may not be fully re-
presentative of the overall respiratory hazard at the locations
studied; as previous reports have emphasized, volcanic ash is a
heterogeneous dust, the physicochemical components of which
can vary considerably, even during a discrete eruption (e.g., Hor-
well et al., 2013a). The inﬂuence of this variability is further evi-
denced here by the disparity in response between explosive and
PDC samples. Therefore, volcanic ash should continue to be con-
sidered on a case-by-case basis to best inform the hazard posed
and most effectively aid mitigation work of disaster managers
globally.
Volcanic
ash
10 µm 10 µm
50 µm
Fig. 6. Uptake of ash by THP-1 cells. Light micrographs of the uptake of volcanic ash by THP-1 cells: (a) untreated cells, (b) cells treated with COL, and (c) low magniﬁcation
view of cells with internalized ash particles (arrows). Images are representative of all samples.
Table 2
Summary of the correlation (slope and coefﬁcient of determination) between
toxicity endpoints and cristobalite content for all samples used in the present
study. Individual plots comparing CS to discrete endpoints available in the Sup-
plementary material.
Indicator of toxicity THP-1 cells A549 cells
Slope R2 value Slope R2 value
Cytokine/chemokine production
IL-1β  0.0194 n/a n/a
IL-6  0.3387  0.0059
IL-8  0.3206  0.0301
Cellular viability
FACS  0.5347 þ 0.0854
LDH release  0.0058  0.4871
AlamarBlue þ 0.5698 þ 0.2900
Oxidative capacity n/a n/a  0.3373
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